v3.26.1
Supplemental Financial Information - Schedule of Supplemental Statement of Cash Flows (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities          
Net income $ 224.8 $ 328.1 $ 82.9 $ 486.7  
Adjustments to reconcile net income to net cash flows from operating activities:          
Depreciation and amortization     101.8 94.6  
Equity-based compensation 116.0 92.9 235.8 196.4  
Non-cash performance allocations and incentive fees     338.9 (250.6)  
Non-cash principal investment (income) loss     (121.5) 32.6  
Other non-cash amounts     (6.4) 36.8  
Purchases of investments     (283.6) (144.3)  
Proceeds from the sale of investments     321.1 469.6  
Payments of contingent consideration     0.0 (1.0)  
Change in deferred taxes, net     (72.4) (16.5)  
Change in due from affiliates and other receivables     (65.4) (16.3)  
Change in deposits and other     7.5 (24.9)  
Change in accounts payable, accrued expenses and other liabilities     55.1 39.1  
Change in accrued compensation and benefits     (243.1) (116.2)  
Change in due to affiliates     3.9 23.6  
Change in lease right-of-use assets and lease liabilities     (7.9) (6.3)  
Change in deferred revenue     7.3 57.6  
Net cash used in operating activities     (1,242.9) (520.9)  
Cash flows from investing activities          
Purchases of fixed assets, net     (60.1) (34.2)  
Net cash used in investing activities     (60.1) (34.2)  
Cash flows from financing activities          
Payments on CLO borrowings     (37.6) (40.1)  
Proceeds from CLO borrowings, net of financing costs     47.8 15.1  
Dividends to common stockholders     (252.1) (252.7)  
Contributions from non-controlling interest holders     799.5 231.3  
Distributions to non-controlling interest holders     (161.1) (198.4)  
Common shares repurchased and net share settlement of equity-based awards     (508.9) (280.1)  
Change in due to/from affiliates financing activities     (208.7) (3.4)  
Net cash provided by financing activities     628.5 526.8  
Effect of foreign exchange rate changes     (41.1) 38.7  
Increase (decrease) in cash, cash equivalents and restricted cash     (715.6) 10.4  
Cash, cash equivalents and restricted cash, beginning of period     1,973.6 1,266.5  
Cash, cash equivalents and restricted cash, end of period 1,258.0 1,276.9 1,258.0 1,276.9  
Reconciliation of cash, cash equivalents and restricted cash, end of period:          
Cash and cash equivalents 1,256.5 1,275.8 1,256.5 1,275.8 $ 1,970.2
Restricted cash 1.5 1.1 1.5 1.1 3.4
Total cash, cash equivalents and restricted cash, end of period 1,258.0 1,276.9 1,258.0 1,276.9 1,973.6
Cash and cash equivalents held at Consolidated Funds 784.1 463.1 784.1 463.1 1,235.1
Consolidated Operating Entities          
Cash flows from operating activities          
Net income     26.1 464.8  
Adjustments to reconcile net income to net cash flows from operating activities:          
Depreciation and amortization     101.8 94.6  
Equity-based compensation     235.8 196.4  
Non-cash performance allocations and incentive fees     335.3 (252.4)  
Non-cash principal investment (income) loss     (12.9) 33.5  
Other non-cash amounts     (6.4) 36.8  
Purchases of investments     (733.1) (481.8)  
Proceeds from the sale of investments     600.6 499.5  
Payments of contingent consideration     0.0 (1.0)  
Change in deferred taxes, net     (72.4) (16.5)  
Change in due from affiliates and other receivables     (66.8) (16.5)  
Change in deposits and other     7.5 (25.0)  
Change in accounts payable, accrued expenses and other liabilities     55.1 39.1  
Change in accrued compensation and benefits     (243.1) (116.2)  
Change in due to affiliates     3.9 23.6  
Change in lease right-of-use assets and lease liabilities     (7.9) (6.3)  
Change in deferred revenue     7.3 57.6  
Net cash used in operating activities     230.8 530.2  
Cash flows from investing activities          
Purchases of fixed assets, net     (60.1) (34.2)  
Net cash used in investing activities     (60.1) (34.2)  
Cash flows from financing activities          
Payments on CLO borrowings     (37.6) (40.1)  
Proceeds from CLO borrowings, net of financing costs     47.8 15.1  
Dividends to common stockholders     (252.1) (252.7)  
Contributions from non-controlling interest holders     208.4 91.4  
Distributions to non-controlling interest holders     (119.1) (48.6)  
Common shares repurchased and net share settlement of equity-based awards     (508.9) (280.1)  
Change in due to/from affiliates financing activities     (206.7) (0.5)  
Net cash provided by financing activities     (868.2) (515.5)  
Effect of foreign exchange rate changes     (18.1) 29.9  
Increase (decrease) in cash, cash equivalents and restricted cash     (715.6) 10.4  
Cash, cash equivalents and restricted cash, beginning of period     1,973.6 1,266.5  
Cash, cash equivalents and restricted cash, end of period 1,258.0 1,276.9 1,258.0 1,276.9  
Reconciliation of cash, cash equivalents and restricted cash, end of period:          
Cash and cash equivalents 1,256.5 1,275.8 1,256.5 1,275.8  
Restricted cash 1.5 1.1 1.5 1.1  
Total cash, cash equivalents and restricted cash, end of period 1,258.0 1,276.9 1,258.0 1,276.9 $ 1,973.6
Cash and cash equivalents held at Consolidated Funds $ 784.1 $ 463.1 $ 784.1 $ 463.1